Cargando…
Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study
AIMS: This randomized controlled trial (RCT) evaluated whether a process with single combined testing of copeptin and troponin at admission in patients with low-to-intermediate risk and suspected acute coronary syndrome (ACS) does not lead to a higher proportion of major adverse cardiac events (MACE...
Autores principales: | Möckel, Martin, Searle, Julia, Hamm, Christian, Slagman, Anna, Blankenberg, Stefan, Huber, Kurt, Katus, Hugo, Liebetrau, Christoph, Müller, Christian, Muller, Reinhold, Peitsmeyer, Philipp, von Recum, Johannes, Tajsic, Milos, Vollert, Jörn O., Giannitsis, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320319/ https://www.ncbi.nlm.nih.gov/pubmed/24786301 http://dx.doi.org/10.1093/eurheartj/ehu178 |
Ejemplares similares
-
Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome
por: Reinhold, Thomas, et al.
Publicado: (2018) -
Biomarkers-in-Cardiology 8 RE-VISITED—Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome—A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial
por: Giannitsis, Evangelos, et al.
Publicado: (2022) -
Copeptin: Limited Usefulness in Early Stroke Differentiation?
por: von Recum, Johannes, et al.
Publicado: (2015) -
Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry
por: Giannitsis, Evangelos, et al.
Publicado: (2019) -
Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings from a large pooled individual data analysis on 10,329 patients
por: Giannitsis, Evangelos, et al.
Publicado: (2020)